IMVT Immunovant, Inc.

HealthcareBiotechnology
$27.22
▼ 5.06%
40
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
31
Short-Term
50

Value

30
P/E-10.64
8
P/B5.01
45
P/S0.00
70
EV/EBITDA-9.44
5

Growth

34
Revenue Growth0.0%
28
EPS Growth-45.2%
40
FCF Growth-75.5%
36

Momentum

78
12-Month Return96.7%
100
3-Month Return13.1%
81
1-Month Return10.1%
72
RSI (14)37.16
50
50/200 MABullish
75

Profitability

18
ROE-65.8%
39
ROA-44.1%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-7.6%
0

Risk

34
Beta0.70
75
60-Day Volatility45.6%
0

Generated 5/7/2026, 10:48:04 PM · How is this calculated?

QScore Analysis